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Objectives:  Vitamin  D  is  involved  in  visual  health  and function.  Our  objective  was  to  determine  whether
age-related  vitamin  D insufﬁciency  was  associated  with  the  presence  and  the  severity  of  primary  open
angle glaucoma  (POAG)  in  a case-control  study  of  older  adults.
Study  design:  Case-control  study.
Main outcome  measures.  One  hundred  ﬁfty cases  diagnosed  with  moderate-to-severe  POAG  (mean,
75.1  ±  8.5  years;  42.0%  female)  and  164 healthy  controls  (mean,  73.0  ±  7.9  years;  59.8% female)  were
included.  POAG  diagnosis  was based  on  classical  diagnostic  criteria  of  optic nerve  cupping  and/or
RNFL  thinning,  measured  with  optical  coherence  tomography.  Severe  POAG  was  deﬁned  as Humphrey
visual  ﬁeld  mean  deviation  (MD)  worse  than  −12  dB.  Vitamin  D  insufﬁciency  was  deﬁned  as  serum
25OHD  ≤ 75  nmol/L.  Age,  gender,  mean  arterial  pressure,  vitamin  D  supplementation,  visual  acuity,  and
intraocular  pressure  were  used  as  potential  confounders.
Results:  POAG  cases  had lower  mean  serum  25OHD  concentration  than  controls  (42.9 ± 25.7 nmol/L  versus
49.4  ±  29.5  nmol/L,  P =  0.039)  and  a greater  prevalence  of  vitamin  D insufﬁciency  (90.7% versus  82.3%,
P  =  0.032).  Increased  mean  serum  25OHD  concentrations  were  associated  with  lower  POAG frequency,
even  after  adjustment  for  potential  confounders  (OR =  0.89  per 10  nmol/L  of  25OHD,  P = 0.045).  Similarly,
vitamin  D  insufﬁciency  was  associated  with  POAG  (OR  =  2.09,  P  =  0.034).  Among  POAG  cases,  no  25OHD
difference  was  observed  between  moderate  and  severe  POAG  cases  (respectively,  39.2  ± 23.3  nmol/L
versus  45.1  ± 26.7  nmol/L,  P =  0.188);  and no  between-group  difference  regarding  the prevalence  of  vita-
min D  insufﬁciency  (88.9%  versus  94.0%, P =  0.313).
Conclusions:  Decreased  serum  25OHD  concentration  was  associated  with  POAG.  There  was  no  25OHD
difference  between  moderate  and severe  POAG.
© 2015  Elsevier  Ireland  Ltd.  All  rights  reserved.
1. Introduction
The primary open-angle glaucoma (POAG), a common chronic
disease of the optic nerve in older adults associated with high
intraocular pressure, is characterized by gradual loss of visual ﬁeld
∗ Corresponding author at: Department of Neuroscience, Angers University Hos-
pital, 49933 Angers Cedex 9, France. Tel.: +33 2 41 35 54 86; fax: +33 2 41 35 48 94.
E-mail address: CeAnnweiler@chu-angers.fr (C. Annweiler).
due to damage of retinal ganglion cells and/or their axons [1–3]. To
date, the pathogenic mechanisms of POAG are not fully elucidated.
Recent ﬁndings have suggested that the serum vitamin D status
could be a biological determinant associated with visual function
and retinal structure in older adults. With advancing age, a decreas-
ing proportion of older adults are able to maintain normal vitamin
D status (from 50% at 60 years of age to less than 20% after 90
years of age) [4]. It is now accepted that the role of vitamin D is
not restricted to bone, but also targets a larger number of non-
bone organs, including the eye [5]. Vitamin D insufﬁciency has
http://dx.doi.org/10.1016/j.maturitas.2015.05.008
0378-5122/© 2015 Elsevier Ireland Ltd. All rights reserved.
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been associated with reduced visual acuity in older adults [6], due
to various causes, including reduced macular health [7]. In non-
human primates, vitamin D eye drops resulted in a reduction of
intraocular pressure by 20%, raising the question of a possible link
between vitamin D status and POAG [8]. The objectives of this case-
control study were to determine whether (i) POAG patients had
lower serum 25-hydroxyvitamin D (25OHD) concentrations com-
pared to healthy controls, and (ii) if POAG severity was associated
with lower serum 25OHD concentrations.
2. Materials and methods
2.1. Participants
We  studied consecutive patients followed in a glaucoma clinic at
the Department of Ophthalmology, University Hospital of Angers,
France, and recruited in the Glaucogen study between 17 December
2013 and 15 July 2014. The Glaucogen study is a case-control study
designed to identify genes of polymorphism as susceptibility fac-
tors for POAG, which included patients aged ≥60 years, diagnosed
with moderate-to-severe POAG, but no other associated intraocular
conditions. Controls were selected from an elderly population (age
≥60 years), fulﬁlling the following inclusion criteria: visual acuity
≥20/50 and no intraocular pathology, except moderate cataract.
Exclusion criteria in the control group were personal or family his-
tory of glaucoma, of ocular hypertension or any other intraocular
pathology, including retinal conditions. For the present analysis,
we included only participants who underwent a serum vitamin D
assay at the time of the inclusion. Thus, four participants without
blood testing were excluded from the analysis. Finally, 150 POAG
cases and 164 controls were included in our analysis.
Participants were included after having given their written
informed consent for research. The study was conducted in
accordance with the ethical standards set forth in the Helsinki
Declaration (1983). The Glaucogen protocol was approved by
the University of Angers Ethical Review Committee (CPP Ouest
2—24/10/2013).
In addition to a full medical examination and blood test
for 25OHD, all included participants underwent an ophthalmic
evaluation, including best-corrected visual acuity, intraocular
pressure, pachymetry, slit-lamp examination, fundoscopy, and
high-deﬁnition optical coherence tomography (HD-OCT) using the
Cirrus device (Carl Zeiss Meditech, Dublin, CA).
2.2. Primary open-angle glaucoma
The diagnosis of chronic POAG was based on consensual crite-
ria, i.e. intraocular pressure >21 mmHg, glaucomatous optic nerve
damage with a cup/disc ratio >0.3, open anterior chamber angle,
and progressive visual ﬁeld loss without signs of secondary glau-
coma or nonglaucomatous cause of optic neuropathy [9].
Standard automated perimetry (Humphrey ﬁeld analyser, Carl
Zeiss, Dublin, CA) using the 24-2 SITA-standard algorithm was  per-
formed in the glaucoma group, and the mean defect (MD) was used
to grade the severity of POAG. The reliability indices retained to
were false positives or false negative under 15% and ﬁxation losses
under 20%. No repetition of the standard automated perimetry was
performed. In our sample with moderate-to-severe POAG, severe
POAG was deﬁned using the classic threshold MD  of worse than
−12 dB [9].
2.3. Serum 25-hydroxyvitamin D concentration
Venous blood was collected from resting participants. Serum
25OHD concentration, an effective indicator of vitamin D status
[4–6,8,10], was measured by radioimmunoassay (DiaSorin corp.,
Stillwater, MN). Intra- and interassay precisions were, respectively,
5.2% and 11.3%. Vitamin D insufﬁciency was consensually deﬁned
as 25OHD concentrations ≤75 nmol/L (to convert to ng/mL, divide
by 2.496) [4]. All measurements were performed locally at the Uni-
versity Hospital of Angers, France.
2.4. Covariables
Age, gender, mean arterial pressure (MAP), vitamin D supple-
mentation, visual acuity, and intraocular pressure were used as
potential confounders in our analysis.
The best-corrected visual acuity was  measured using decimal
Monoyer charts and converted into logMAR units for statistical
analysis purposes. Intraocular pressure was measured using Gold-
mann applanation tonometer. For the analysis, we included data
from the most affected eye in POAG patients and from the right
eye, in healthy controls. Blood pressure was measured at rest in a
quiet environment by trained nurses according to a standardized
protocol [11] using a sphygmomanometer placed on the brachial
artery with arm at heart level. The MAP  (i.e., the average BP over
the entire course of the BP cycle) was calculated in mmHg  from sys-
tolic (SBP) and diastolic blood pressures (DBP) using the following
formula: MAP  = (SBP + 2 DBP)/3 [12]. The regular use of vitamin D
supplements was reported by direct inquiry, whatever the dosage
schedule or route of administration, and regardless of the date of
commencement.
2.5. Statistical analysis
The participants’ characteristics were summarized using means
and standard deviations (SD) or frequencies and percentages, as
appropriate. Normality of data distribution was checked using
skewness–kurtosis test. As the number of observations was higher
than 40, comparisons were not affected by the shape of the error
distribution and no transform was applied [12]. First, compar-
isons between cases with POAG and controls were performed using
Student’s t-test or the Chi-square test, as appropriate. Second,
univariate and multiple logistic regressions were used to exam-
ine the association between serum 25OHD (independent variable)
and POAG (dependent variable), while adjusting for potential con-
founders. Third, a t-test and a Chi-square test were used among
cases to compare the serum 25OHD concentration and the preva-
lence of vitamin D insufﬁciency between those with severe POAG
(i.e., MD worse than −12 dB) and those with moderate POAG (i.e.,
MD better than −12 dB). A Pearson correlation was  also used to
determine whether the serum 25OHD correlated with MD among
cases. P-values <0.05 were considered signiﬁcant. All statistics were
performed using SPSS (v19.0, IBM Corporation, Chicago, IL).
3. Results
One hundred ﬁfty cases with POAG (mean ± standard deviation,
75.1 ± 8.5 years; 42.0% female;) and 164 controls (73.0 ± 7.9 years,
59.8% female) were included in the study. The design of the study
imposed inclusion of moderate-to-severe POAG cases, explain-
ing the visual ﬁeld impairment (mean MD,  −17.2 ± 7.9 dB). There
were more cases with severe POAG (n = 99, 66% with MD > −12 dB)
than moderate POAG. Overall, the mean 25OHD concentration
was 46.3 ± 27.9 nmol/L; vitamin D insufﬁciency was found in 271
of the included participants (86.3%). As illustrated in Table 1,
POAG cases had lower serum 25OHD concentration than controls
(42.9 ± 25.7 nmol/L versus 49.4 ± 29.5 nmol/L, P = 0.039). Vitamin
D insufﬁciency was  more frequently present in POAG cases than
in controls free of POAG (90.7% versus 82.3%, P = 0.032). POAG
cases were older (P = 0.025), with a higher MAP  (P = 0.005), and
with a greater proportion of males (P = 0.002), than controls.
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Table  1
Characteristics and comparison* of cases with primary open-angle glaucoma (n = 150) and matched controls without primary open-angle glaucoma (n = 164).
Total sample (n = 314) Primary open-angle glaucoma P-value*
Yes (n = 150) No (n = 164)
Demographical and clinical measures
Age (years) 74.0 ± 8.2 75.1 ± 8.5 73.0 ± 7.9 0.025
Female gender, n (%) 161 (51.3) 63 (42.0) 98 (59.8) 0.002
Mean  arterial pressure (mmHg) 100.0 ± 12.6 102.2 ± 12.4 98.1 ± 12.6 0.005
Vitamin D supplementation, n (%) 98 (31.2) 45 (30.0) 53 (32.7) 0.606
Season of evaluation 0.202
Spring, n (%) 121 (38.5) 49 (32.7) 72 (43.9)
Summer, n (%) 33 (10.5) 19 (12.7) 14 (8.5)
Fall,  n (%) 8 (2.5) 4 (2.7) 4 (2.4)
Winter, n (%) 152 (48.4) 78 (52.0) 74 (45.1)
Ophthalmic measures
Visual acuity† (logMAR) 1.8 ± 0.5 1.8 ± 0.5 1.8 ± 0.4 0.597
Axial  length† (m) 23.6 ± 1.2 23.9 ± 1.2 23.4 ± 1.1 0.001
Intraocular pressure† (mmHg) 14.5 ± 3.6 14.0 ± 4.3 15.0 ± 2.8 0.020
Macular thickness† (m) 265.0 ± 63.1 267.0 ± 81.6 262.7 ± 29.3 0.601
RNFL  thickness† (m)  71.5 ± 16.5 60.6 ± 9.2 88.7 ± 8.9 <0.001
Cup-to-disc ratio† (%) 68.9 ± 20.9 81.8 ± 10.2 47.6 ± 16.0 <0.001
Primary open-angle glaucoma
Right eye most affected, n (%) – 66 (44.0) – –
Disease duration since diagnosis (years) – 14.9 ± 8.8 – –
Mean  defect†
Mean (dB) – −17.2 ± 7.9 – –
Severe‡ , n (%) – 99 (66.0) – –
Serum  measures
Mean 25-hydroxyvitamin D concentration (nmol/L) 46.3 ± 27.9 42.9 ± 25.7 49.4 ± 29.5 0.039
Vitamin D insufﬁciency#, n (%) 271 (86.3) 136 (90.7) 135 (82.3) 0.032
Data presented as mean ± standard deviation where applicable. RNFL: retinal nerve ﬁbre layer.
* Comparisons between participants with and without primary open-angle glaucoma based on t-test or Chi-square, as appropriate.
† Measure on most affected eye among cases with primary open-angle glaucoma, and on right eye among controls without primary open-angle glaucoma.
‡ Mean defect worse than −12 dB.
# Serum 25-hydroxyvitamin D ≤ 75 nmol/L; P-value signiﬁcant (i.e., P < 0.05) indicated in bold.
Unsurprisingly, POAG cases had signiﬁcantly thinner RNFL on OCT
measurements (P < 0.001) and higher cup-to-disc ratio (P < 0.001),
as well as lower intraocular pressure (P = 0.020) than controls. In
contrast, there were no between-group differences regarding the
season of inclusion (P = 0.202), the use of vitamin D supplements
(30.0% vs 32.7%, P = 0.606), the visual acuity (P = 0.597) and the
macular thickness (P = 0.601).
Table 2 shows univariate and multiple logistic regressions
between serum 25OHD concentration and the diagnosis of POAG.
Increased serum 25OHD concentration was associated with less
frequent POAG diagnosis (unadjusted OR = 0.92 per 10 nmol/L of
25OHD, P = 0.041), even after adjustment for all potential con-
founders (OR = 0.89 per 10 nmol/L of 25OHD, P = 0.045). Similarly,
vitamin D insufﬁciency was associated with POAG diagnosis
(OR = 2.09 [95% conﬁdence interval: 1.06–4.12], P = 0.034).
Regarding POAG severity, 99 cases (66.0%) with moderate POAG
(i.e. mean MD  better than −12 dB) exhibited a mean serum 25OHD
concentration of 45.1 ± 26.7 nmol/L, while severe POAG patients
(MD worse than −12 dB) had a mean 25OHD of 39.2 ± 23.3 nmol/L
(P = 0.188). There was no between-group difference regarding the
prevalence of vitamin D insufﬁciency (88.9% in cases with severe
POAG versus 94.0% in cases with moderate POAG, P = 0.313). Finally,
the serum concentration of 25OHD did not correlate with MD
among POAG cases (r = −0.11, P = 0.200), neither with predictors for
worsening of POAG like intraocular pressure (r = −0.36, P = 0.531)
and vertical cup-to-disc ratio (r = −0.034, P = 0.604).
4. Discussion
The main ﬁnding of the present case-control study is that
the group of POAG patients had 15-percent lower serum 25OHD
concentrations, and exhibited more often vitamin D insufﬁciency
than controls. The association of POAG with decreased serum
25OHD concentration remained signiﬁcant after adjustment for
all measured potential confounders. In contrast, there was no
correlation between serum 25OHD concentration and the POAG
severity.
These ﬁndings are consistent with the growing epidemiological
evidence on the deleterious effect of vitamin D insufﬁciency on eye
health and function [6,7,13,14]. While previous research was pri-
marily focused on macular conditions such as AMD  [15,16], only
one clinical study focused speciﬁcally on the association between
vitamin D and POAG [17]. Yoo et al. showed among 6,094 adults
an inverse association between POAG (n = 290; mean, 63.3 ± 10.7
years; 53.1% female) and serum 25OHD concentration (OR  = 0.98
with P = 0.04 for 1 ng/mL increase in 25OHD) [17]. However, vari-
ous limitations of this study, including its cross-sectional design,
precluded any conclusion regarding an involvement of vitamin
D insufﬁciency in POAG. Also, vitamin D supplementation, an
important potential confounder, was  not taken into account in the
mentioned study. It is yet well-recognized that supplementation
is the main exogenous source of vitamin D in older adults due to
decreased level of 7-dehydrocholesterol in the skin with aging and
reduced digestive absorption [10]. Unlike the latter study, our study
was based on a case-control design, and analyses were adjusted
for the use of vitamin D supplements, making our results robust.
Despite these methodological differences, both studies consistently
found that lower 25OHD concentration was  associated with POAG.
However, unlike Yoo et al., we found no signiﬁcant correlation
between 25OHD concentration and predictors for POAG worsen-
ing like mean defect, intraocular pressure or vertical cup-to-disc
ratio. Thus, our data suggests that serum 25OHD level may rather
be a marker associated with the presence rather than the severity
of POAG.
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Table 2
Univariate and multiple logistic regression models examining the cross-sectional association between serum 25-hydroxyvitamin D (25OHD) concentration (independent
variable) and primary open-angle glaucoma (dependent variable), adjusted for potential confounders (n = 314).
Primary open-angle glaucoma
Unadjusted model Fully adjusted model
OR [95%CI] P-value OR [95%CI] P-value
Serum 25OHD concentration* 0.92 [0.84–0.99] 0.041 0.89 [0.80–0.99] 0.045
Age  1.03 [1.00–1.06] 0.026 1.02 [0.98–1.05] 0.331
Female gender 0.49 [0.31–0.77] 0.002 0.55 [0.32–0.94] 0.029
Mean  arterial pressure 1.03 [1.01–1.05] 0.006 1.03 [1.01–1.05] 0.010
Vitamin D supplementation 0.88 [0.55–1.42] 0.606 1.19 [0.61–2.29] 0.611
Visual acuity 1.14 [0.70–1.88] 0.596 1.22 [0.70–2.13] 0.490
Intraocular pressure 0.93 [0.87–0.99] 0.022 0.88 [0.81–0.96] 0.004
CI: conﬁdence interval; OR: odds ratio.
* Per 10 nmol/L of serum 25-hydroxyvitamin D; OR signiﬁcant (i.e., P-value <0.05) indicated in bold.
However, it is not clear whether the association between lower
vitamin D and POAG is causal. Alternatively, it can be argued
that older individuals with POAG and visual dysfunction are more
likely to have impaired functional abilities [10,18,19], leading
subsequently to reduced vitamin D intakes, sun exposure and con-
sequently lower 25OHD concentrations. However, no dedicated
functional score is available in the studied cohort to support this
assumption. Alternatively, it has been speculated that decreased
25OHD concentration might increase the risk for POAG. In line with
a potential role of vitamin D in the pathophysiology of POAG, are
the following arguments:
(i) Vitamin D may  play a role in the regulation of the intraocular
pressure [20]. In an animal study, vitamin D eye drops in non-
human-primates resulted in a reduction of intraocular pressure
by 20%, mainly by increasing the uveoscleral outﬂow [8]. On the
opposite, a randomized controlled intervention trial involving
humans found no IOP reduction after high-dose vitamin D3 sup-
plementation (20,000 IU twice per week) during 6 months [20].
In our study, POAG cases were exhibiting lower IOP compared
to controls (Table 1), probably due to appropriate POAG treat-
ments (the vitamin D supplementation being similar in both
groups).
(ii) A second speculative approach is to consider that vitamin
D insufﬁciency is linked to generalized neurodegeneration,
including POAG. Such tight interconnections between brain
and retina have prompted several authors to consider the eye
as a privileged window to the brain, allowing early diagnosis
and monitoring of neurodegenerative disease [21]. It is nowa-
days accepted that vitamin D insufﬁciency is associated with
all-cause dementia and Alzheimer disease [22,23], a condi-
tion in which retinal ganglion cell loss and RNFL thinning can
be detected with OCT [21,24]. Indeed, a common mechanism
has been proposed to explain both retinal degeneration and
Alzheimer disease [25]. Various neuroprotective effects of vita-
min  D in the CNS and the eye may  explain these associations. In
vitro, vitamin D increases the synthesis of neurotrophic agents
such as the Nerve Growth Factor (NGF) and the Glial cell line-
Derived Neurotrophic Factor (GDNF), and regulates neuronal
differentiation and maturation [26,27]. It also accelerates neu-
ronal growth in a dose-dependent way in rat hippocampal cell
cultures [28]. Parallel, the anti-inﬂammatory properties of vita-
min  D may  be involved as there is evidence for a pivotal role of
vitamin D in the immune system [29,30] by modulating effect
on the immune cells that produce vitamin D and express the
VDR. Finally, the antioxidant properties of vitamin D against
oxidative stress of reactive oxygen and nitrogen species in the
central nervous system [31] should also be mentioned.
The strengths of the present study include (i) the originality
of the research question in POAG, which is a highly common,
potentially blinding condition, (ii) the detailed description of the
participants’ characteristics allowing the use of regression models
to measure adjusted associations, and (iii) the standardized col-
lection of data from a single research centre. In addition, enrolling
patients in a single centre allowed to centralize vitamin D assays in a
single laboratory and to avoid inter-laboratory variability. Regard-
less, our study also has some limitations. First, the case-control
design of our study is less robust than a prospective longitudinal
cohort study. Second, the study cohort was restricted to 314 older
patients, who  might be unrepresentative of the population of glau-
comatous patients. Third, although we  excluded from the control
group the participants with corneal and retinal conditions, controls
had mild cataract, which may  limit the interpretation of results.
In conclusion, we found that decreased 25OHD concentration
was directly associated with the presence of POAG, but not its sever-
ity. This result suggests that vitamin D may  be linked to POAG.
Although the present ﬁndings meet most of Hill’s criteria of causa-
tion including strength, dose–response relationship, consistency,
plausibility, consideration of alternate explanations, experiment,
and coherence [32], we could not provide answers to the issues of
temporality (which is an essential criterion of causation) and speci-
ﬁcity (which is a minor criterion). To ﬁrmly establish causation,
prospective observational cohorts and randomized clinical inter-
vention trials are needed on a variety of adult acute care units.
Before such evidence is available, our ﬁndings provide a ratio-
nale for measuring and correcting, if necessary, vitamin D levels
in patients with POAG.
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